Neucell Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Neucell Pharma
Neucell Pharma Private Limited (NPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 25 February 2021 (Three years and 11 months 6 days old ). Its registered office is in Bhiwani, Haryana, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Purushotam Kumar and Ashok Kumar serve as directors at the Company.
Company Details
-
Location
Bhiwani, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52599HR2021PTC093200
-
Company No.
093200
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Feb 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Neucell Pharma Private Limited offer?
Neucell Pharma Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Digestive Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Common Disease Medicines, Pharmaceutical Tablets, Pharmaceutical Capsules, Antiemetic.
Who are the key members and board of directors at Neucell Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purushotam Kumar
|
Director | 25-Feb-2021 | Current |
|
Ashok Kumar
|
Director | 25-Feb-2021 | Current |
Financial Performance of Neucell Pharma.
Enhance accessibility to Neucell Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neucell Pharma?
Unlock access to Neucell Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Orphee Lifesciences LlpAshok Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neucell Pharma?
Unlock and access historical data on people associated with Neucell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neucell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neucell Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.